Samantha B. Shapiro, MSc retweetledi

New real world data analyses determine yet again, that use of GLP-1 receptor agonists was not associated with an increased risk of suicidality compared with the use of DPP-4 inhibitors or SGLT-2 inhibitors in patients with type 2 #diabetes bmj.com/content/388/bm… @bmj_latest
English














